Stay updated with breaking news from Eric Soyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
▪Entry into a definitive merger agreement between ERYTECH and PHERECYDES ▪Completion of a contribution in kind of PHERECYDES shares to ERYTECH ... | May 16, 2023
ERYTECH Provides Update on the Announced Combination with PHERECYDES Entry into a definitive merger agreement between ERYTECH and PHERECYDESCompletion... | May 15, 2023
ERYTECH Provides Update on the Announced Combination with PHERECYDES Entry into a definitive merger agreement between ERYTECH and PHERECYDESCompletion of a contribution in kind of PHERECYDES
ERYTECH Provides Business and Financial Update for the First Quarter of 2023 Combination with Pherecydes, intending to create a global leader in extended phage therapies to target antimicrobial
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market Cambridge, MA (U.S.) and Lyon (France), April 17, 2023 - ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage